Akero Therapeutics Statistics

Total Valuation

FRA:0K4 has a market cap or net worth of EUR 3.85 billion. The enterprise value is 3.01 billion.

Market Cap	3.85B
Enterprise Value	3.01B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	82.32M
Shares Outstanding	n/a
Shares Change (YoY)	+23.38%
Shares Change (QoQ)	+0.35%
Owned by Insiders (%)	1.40%
Owned by Institutions (%)	98.86%
Float	69.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	4.72
P/TBV Ratio	4.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.04
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.83, with a Debt / Equity ratio of 0.00.

Current Ratio	15.83
Quick Ratio	15.48
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-71.46

Financial Efficiency

Return on equity (ROE) is -34.53% and return on invested capital (ROIC) is -23.81%.

Return on Equity (ROE)	-34.53%
Return on Assets (ROA)	-22.63%
Return on Invested Capital (ROIC)	-23.81%
Return on Capital Employed (ROCE)	-34.45%
Revenue Per Employee	n/a
Profits Per Employee	-3.33M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +58.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+58.04%
50-Day Moving Average	44.60
200-Day Moving Average	41.98
Relative Strength Index (RSI)	59.65
Average Volume (20 Days)	4

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-281.27M
Pretax Income	-249.57M
Net Income	-249.57M
EBITDA	-281.25M
EBIT	-281.27M
Earnings Per Share (EPS)	-3.19

Full Income Statement

Balance Sheet

The company has 628.85 million in cash and 515,642 in debt, giving a net cash position of 841.83 million.

Cash & Cash Equivalents	628.85M
Total Debt	515,642
Net Cash	841.83M
Net Cash Per Share	n/a
Equity (Book Value)	816.19M
Book Value Per Share	10.18
Working Capital	602.48M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-213.22M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:0K4 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.38%
Shareholder Yield	-23.38%
Earnings Yield	-6.47%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1